XML 41 R34.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Earnings Per Common Share (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Earnings Per Share [Abstract] |
Components of Basic and Diluted EPS Computations | The following tables summarize the components of the basic and diluted EPS computations (in thousands, except per share amounts):
|  | Three Months Ended March 31, |
|  | 2024 |  |  | 2023 |
EPS — basic: |  |  |  |  |  |
Net income (loss) (numerator) |  | $ | 10,630 |  |  | $ | (9,795 | )
Weighted average common shares (denominator) |  |  | 270,356 |  |  |  | 263,969 |
Net income (loss) per share |  | $ | 0.04 |  |  | $ | (0.04 | )
EPS — diluted: |  |  |  |  |  |
Net income (loss) — basic |  | $ | 10,630 |  |  | $ | (9,795 | )
Effect of interest and amortization expense on convertible notes |  |  | 1,856 |  |  |  | — |
Adjusted net income (loss) (numerator) |  | $ | 12,486 |  |  | $ | (9,795 | )
Weighted average common shares |  |  | 270,356 |  |  |  | 263,969 |
Effect of dilutive securities — common shares issuable |  |  | 54,377 |  |  |  | — |
Adjusted weighted average common shares (denominator) |  |  | 324,733 |  |  |  | 263,969 |
Net income (loss) per share |  | $ | 0.04 |  |  | $ | (0.04 | )
For the three months ended March 31, 2024, diluted net income per share excluded the weighted average effect of 5.4 million RSUs and Market RSUs and 2.1 million options and PNQs as they were antidilutive.
Potential Dilutive Securities Outstanding that are Considered Antidilutive | Potentially dilutive securities outstanding which were considered antidilutive are summarized as follows (in shares):
|  | Three Months Ended March 31, |
|  | 2023 |
Senior convertible notes |  |  | 44,120,463 |
RSUs and Market RSUs(1) |  |  | 15,468,000 |
Common stock options and PNQs |  |  | 8,943,899 |
Mann Group convertible notes |  |  | 3,370,000 |
Total shares |  |  | 71,902,362 |
__________________________ (1) Market RSUs issued in 2020, 2021 and 2022 are included at the share delivery of 300%, 0% and 210%, respectively, in accordance with a valuation assessment obtained as of March 31, 2023.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration